John Goldberg

Dr. Goldberg is Acting Chief Development Officer at Incendia, responsible for driving the company’s human trials to proof of concept, and for communicating our clinical progress and vision to external stakeholders. He brings 21 years of experience in academic and industry drug development to Incendia, and his most recent roles include Chief Medical Officer at Rafael Holdings, a family office where he advised the principal on new asset investment, and Chief Medical Officer at Oncorus, a venture backed immunotherapy company where he led clinical and helped with significant fundraising efforts. Before Oncorus, he held positions in industry at H3 Biomedicine and Agenus. He led the pediatric oncology Phase 1 program at the University of Miami from 2008-2015.

Dr. Goldberg trained in pediatric hematology-oncology at Dana-Farber/Boston Children’s Hospital and in general pediatrics at the University of Rochester. He holds an MD from the University of Massachusetts Chan Medical School, an AB in Biological Sciences from the University of Chicago and serves on the Medical Advisory Board of the Sarcoma Foundation of America.